Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06378554Not ApplicableEnrolling By Invitation

Cereset Research for Performance Improvement in a Hospital Nursing Unit

Role: collaborator

NCT05994261Not ApplicableCompleted

Cereset Research Long-Term Healthcare Worker Study

Role: collaborator

NCT04682197Not ApplicableCompleted

Cereset Research In Healthcare Workers During COVID-19

Role: collaborator

NCT05229107Not ApplicableWithdrawn

Cereset Research For Chronic Nausea

Role: collaborator

All 4 trials loaded